NCT04014023View on ClinicalTrials.gov

Study to Evaluate the Efficacy and Safety of DWP16001 in Patients With Type 2 Diabetes Mellitus

PHASE2UnknownINTERVENTIONAL
Enrollment

196

Participants

Timeline

Start Date

July 10, 2019

Primary Completion Date

March 31, 2020

Study Completion Date

June 30, 2020

Conditions
T2DM (Type 2 Diabetes Mellitus)
Interventions
DRUG

DWP16001

DWP16001 tablets

DRUG

Placebo

DWP16001 placebo-matching tablets

Trial Locations (1)

Unknown

RECRUITING

Daewoong pharmatceutical, Seoul

Sponsors
All Listed Sponsors
lead

Daewoong Pharmaceutical Co. LTD.

INDUSTRY